Pharmacodynamic Effects of Vorapaxar in Prior Myocardial Infarction Patients Treated With Potent Oral P2Y(12) Receptor Inhibitors With and Without Aspirin: Results of the VORA‐PRATIC Study

BACKGROUND: Vorapaxar as an adjunct to dual antiplatelet therapy (DAPT) reduces thrombotic events in patients with prior myocardial infarction at the expense of increased bleeding. Withdrawal of aspirin has emerged as a bleeding reduction strategy. The pharmacodynamic effects of vorapaxar with poten...

詳細記述

保存先:
書誌詳細
出版年:J Am Heart Assoc
主要な著者: Franchi, Francesco, Rollini, Fabiana, Faz, Gabriel, Rivas, Jose Ramon, Rivas, Andrea, Agarwal, Malhar, Briceno, Maryuri, Wali, Mustafa, Nawaz, Ahmed, Silva, Gabriel, Shaikh, Zubair, Maaliki, Naji, Fahmi, Kerolos, Been, Latonya, Pineda, Andres M., Suryadevara, Siva, Soffer, Daniel, Zenni, Martin M., Baber, Usman, Mehran, Roxana, Jennings, Lisa K., Bass, Theodore A., Angiolillo, Dominick J.
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2020
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7428520/
https://ncbi.nlm.nih.gov/pubmed/32306797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.120.015865
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料